MERILISA HIV GEN 4
Product Overview- Merilisa HIV Gen 4 is an enzyme immunoassay for the qualitative determination of HIV p24 antigen and antibodies to Human Immunodeficiency Virus type 1 (HIV-1) and type 2 (HIV-2) in human serum or plasma. Merilisa HIV Gen 4 detects HIV p24 antigen in addition to IgG, IgA and IgM antibodies to the core and envelope glycoproteins of HIV 1-2 by using p24 monoclonal antibodies and recombinant proteins of gp41, gp120 and gp36 representing the immunodominant regions of HIV 1-2
- Streptavidin biotin technology
- Simultaneous detection of Antibodies and Antigens
- Monoclonal Antibodies for p24 Ag detection
- Simultaneous detection of HIV p24 antigen and antibodies to Human Immunodeficiency virus types 1 (HIV- 1) and 2 (HIV - 2)
-
Features
-
Assay
-
FAQs
-
- Monoclonal Antibodies for p24 Ag detection
- Analytical sensitivity : 10 IU/ml for p24 Ag
- Separate positive controls for Antigen and Antibody
- Adaptable on all automated ELISA processors
-
- Simultaneous detection of HIV p24 antigen and antibodies to Human Immunodeficiency virus types 1 (HIV- 1) and 2 (HIV - 2)
-
-
What does 4th Gen refer to?
This indicates that this assay can detect IgG/IgM and IgA antibodies as well as p24 Antigen against HIV-1 & 2
-
How is sensitivity & specificity enhanced?
Using streptavidin & biotin technology
-
How much time does the assay take?
90 mins incubation
-
What is coated on microplate?
Recombinant Antigen (gp41 & 120- HIV-1 & gp-36-HIV-2) as well as monoclonal antibodies for simultaneous detection of both antibodies & p24 Antigen respectively.
-
Who has evaluated the product?
NIB
-